Tokyo, Sept. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058448) titled 'Nasal Allergen Specific IgE Detection Study' on Sept. 1.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponsor:
Institute - International University of Health and Welfare
Condition:
Condition - Allergic Rhinitis
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To investigate the usefulness of measuring allergen-specific IgE in nasal secretions as a diagnostic method for allergic rhinitis.
Basic objectives2 - Others
Intervention:
Interventions/Control_1 - Collection of nasal secretion
Eligibility:
Age-lower limit - 18
years-old
=
Gender - Male and Female
Key inclusion criteria - Patients who are receiving care at the International University of Health and Welfare Narita Hospital and have already undergone blood collection
Patients from whom written informed consent for participation in the study can be voluntarily obtained
Patients aged 18 years or older and under 80 years at the time of consent
Inpatients
Patients confirmed to be negative for HBV and HCV by blood tests
Key exclusion criteria - Patients from whom informed consent could not be obtained
Patients who are using intranasal steroid sprays or systemic steroid medications
Target Size - 80
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 05 Month 30 Day
Anticipated trial start date - 2025 Year 09 Month 01 Day
Last follow-up date - 2030 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066829
Disclaimer: Curated by HT Syndication.
